title: Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient.
abstract: OBJECTIVE
  We describe a rare case of anaphylaxis and thrombocytopenia whose cause was heparin used during hemodialysis sessions.
  
  
  METHODS
  A 77-year-old woman suffered five consecutive episodes of vomiting, tachypnea, wheezing or rales, immediately after initiating hemodialysis. In the first of these episodes, arterial pressure was undetectable. In all of the episodes there was evidence of the presence of hypoxia (always below 60 mmHg) and thrombocytopenia (always below l00,000/microl,, with partial platelets recovery among episodes. The episodes started immediately after hemodialysis sessions and heparin infusion; either sodium heparin or enoxaparin was used. Utilization of different filters was not able to stop the episodes. These were stopped when a switch from heparin to hirudin was tested. Tryptase levels, as a marker of mast cells activation and anaphylaxis, were not increased in two of the episodes which were assessed. IgG antibodies against heparin-PF4 complex was detected at high levels.
  
  
  CONCLUSIONS
  A diagnosis of concomitant anaphylaxis and thrombocytopenia caused by sodium heparin and a low-molecular weight heparin (enoxaparin) were assumed.
authors.affiliation: Allergy, Fundaciń Hospital Alcorcón, Madrid, Spain. nurimang@idecnet.com
authors.forename: M A
authors.initials: MA
authors.lastname: Tejedor Alonso
authors.forename: K
authors.initials: K
authors.lastname: López Revuelta
authors.forename: M J
authors.initials: MJ
authors.lastname: García Bueno
authors.forename: M L
authors.initials: ML
authors.lastname: Casas Losada
authors.forename: A
authors.initials: A
authors.lastname: Rosado Ingelmo
authors.forename: E
authors.initials: E
authors.lastname: Gruss Vergara
authors.forename: C
authors.initials: C
authors.lastname: Vila Albelda
authors.forename: M
authors.initials: M
authors.lastname: Moro Moro
mesh_terms: D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced*; D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D006493:Heparin